MedicarePartD.guide

A non-government resource built from CMS public data

Tresiba on Blue Shield Rx Enhanced (S2468-004)

insulin degludec

Covered.

Tier 3 (preferred brand). Quantity limit of 30 per 30 days.

$52.89
Patient pays / month
$158.67
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

TRESIBA 100 U/mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $278.37 for a month. Other covered strengths are listed below.

All 3 covered strengths and forms
FormTierPatient pays / monthLimits
TRESIBA 200 U/mL Injection, Solution3$95.0127 per 30 days
TRESIBA 100 U/mL Injection, Solution3$52.8930 per 30 days
TRESIBA 100 U/mL Injection, Solution3$53.1030 per 30 days

Other Long-acting insulin on this plan

Verify with the plan before prescribing or filling. Member services: (888)239-6469. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s2468-004